FGS involves the administration of a fluorescent dye, either intravenously or directly into the tumor. These dyes are designed to bind specifically to cancer cells or the surrounding stroma. Under specialized lighting and imaging systems, the fluorescence emitted by these dyes allows surgeons to distinguish cancerous tissue from healthy tissue in real-time.
